Medications for Multiple Myeloma

17 results

  • abecma

    (Idecabtagene Vicleucel)
    Celgene Corporation
    Abecma treats adult patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
    Medication Details
    Drug Interactions

  • aphexda - motixafortide injection, powder, lyophilized, for solution

    (Motixafortide)
    Biolinerx Usa Inc
    Aphexda is used with filgrastim (G-CSF) to mobilize hematopoietic stem cells into the bloodstream for collection and autologous transplantation in patients with multiple myeloma.
    Medication Details

  • carvykti

    (Ciltacabtagene Autoleucel)
    Janssen Biotech, Inc
    CARVYKTI treats adults with relapsed or refractory multiple myeloma who have received at least 1 prior therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.
    Medication Details
    Drug Interactions

  • darzalex - daratumumab injection, solution, concentrate

    (Daratumumab)
    Janssen Biotech, Inc.
    DARZALEX treats multiple myeloma in adults — used in newly diagnosed patients ineligible or eligible for stem cell transplant, and in relapsed/refractory cases after one or more prior therapies, as part of various combination regimens or as monotherapy.
    Medication Details
    Drug Interactions

  • darzalex faspro - daratumumab and hyaluronidase - fihj

    (Daratumumab And Hyaluronidase-Fihj (Human Recombinant))
    Janssen Biotech, Inc.
    DARZALEX FASPRO treats adult patients with multiple myeloma (newly diagnosed or relapsed/refractory, across various combination regimens), high-risk smoldering multiple myeloma, and newly diagnosed light chain (AL) amyloidosis. Not recommended for AL amyloidosis with NYHA Class IIIB/IV cardiac disease outside clinical trials.
    Medication Details
    Drug Interactions

  • elrexfio - elranatamab - bcmm injection, solution

    (Elranatamab-Bcmm)
    Pfizer Laboratories Div Pfizer Inc
    Elrexfio treats relapsed or refractory multiple myeloma in adults who have received at least four prior therapies, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. Approved under accelerated approval based on response rate.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • empliciti - elotuzumab injection, powder, lyophilized, for solution

    (Elotuzumab)
    E.R. Squibb & Sons, L.L.C.
    Empliciti treats multiple myeloma in adults, combined with lenalidomide and dexamethasone after one to three prior therapies, or with pomalidomide and dexamethasone after at least two prior therapies including lenalidomide and a proteasome inhibitor.
    Medication Details
    Drug Interactions

  • kyprolis - carfilzomib injection, powder, lyophilized, for solution

    (Carfilzomib)
    Onyx Pharmaceuticals, Inc.
    Kyprolis (carfilzomib) treats relapsed or refractory multiple myeloma in adults after one or more prior therapies. Used as a single agent or combined with lenalidomide, dexamethasone, daratumumab, isatuximab, or daratumumab/hyaluronidase-fihj plus dexamethasone.
    Medication Details
    Drug Interactions

  • mozobil - plerixafor injection, solution

    (Plerixafor)
    Sanofi-Aventis U.S. Llc
    Mozobil is used with filgrastim to mobilize hematopoietic stem cells into the bloodstream for collection and autologous transplantation in adults with non-Hodgkin's lymphoma or multiple myeloma.
    Medication Details
    Drug Interactions

  • ninlaro - ixazomib capsule

    (Ixazomib)
    Takeda Pharmaceuticals America, Inc.
    Ninlaro is used with lenalidomide and dexamethasone to treat multiple myeloma in adults who have had at least one prior therapy. Not recommended for maintenance use or newly diagnosed patients outside controlled clinical trials.
    Medication Details
    Drug Interactions